Needham & Company LLC

needham-company-affirms-buy-rating-for-par-technology-stock

Needham & Company Affirms Buy Rating for PAR Technology Stock

Editorial 11 July, 2025

Research analysts at Needham & Company LLC have reaffirmed their “buy” rating for PAR...

brokerages-boost-moonlake-immunotherapeutics-price-target-to-74-50

Brokerages Boost MoonLake Immunotherapeutics Price Target to $74.50

Editorial 11 July, 2025

Shares of MoonLake Immunotherapeutics (NASDAQ:MLTX) have received a consensus rating of “Buy” from seven...